TNTomas Novosad

Tomas Novosad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tomas Novosad has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Eva Kriegova

    Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic

    2 shared publications
  • Jakub Savara

    Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic; Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic

    2 shared publications
  • Petr Gajdoš

    VSB-Technical University of Ostrava Department of Computer Science, Faculty of Electrical Engineering and Computer Science 17. listopadu 2172/15, 70800 Ostrava

    2 shared publications
  • Anna Petrackova

    Palacký University Olomouc and University Hospital Olomouc Department of Immunology, Faculty of Medicine and Dentistry Hnevotinska 3, 77900 Olomouc

    1 shared publication
  • Filip Čtvrtlík

    Department of Radiology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic

    1 shared publication
  • Jiri Minarik

    Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic

    1 shared publication

Latest Publications

  • Open Access

    Multiplatform comparisons and annotation of structural variants highlight the utility of the T2T reference genome in human diagnostics

    by Jakub Savara, Tomas Novosad, Petr Gajdos, Anna Petrackova, Marek Behalek, Jirina Manakova, Filip Ctvrtlik, Jiri Minarik, Tomas Papajik, Eva Kriegova

    Background: Structural variants (SVs) are increasingly recognized as key contributors to human diseases. However, our understanding of SVs in health and disease is limited, mainly due to their structural complexity and variable length in individuals, as well as limitations inherent to the available genomic technologies and reference genome used. Results: To systematically evaluate SVs across human whole-genome samples using hg38/GRCh38 and gapless T2T-CHM13 references, we introduced an innovative multiplatform approach, LongReadChecker (LoReC), which advances SV comparison and annotation based on distance variance, intersection, gene overlap, and the closest SV in the clinical database. Comparison of the performance in detecting SVs from public and our own whole-genome datasets from short-read sequencing (SRS), available long-read sequencing (LRS) platforms, and optical genome mapping (OGM) revealed that most SVs detected by SRS were confirmed by LRS, but LRS can identify twice as many SVs (25,000 SVs/genome) with greater read mapping accuracy. Our LongReadChecker (LoReC) analysis further highlights the utility of the T2T-CHM13 reference in SV detection, as 20% more deletions and 20% less insertions were detected compared with hg38/GRCh38, which was particularly evident in long-read datasets. Since 80% of the SVs detected by LRS/SRS are smaller than 0.5 kbp, OGM did not detect them. Conclusions: Our study revealed that introducing distance variance, intersection, gene overlap, and the closest SV in the clinical database may help compare and annotate SVs in diagnostics. Our data showed that LRS, together with T2T-CHM13 gapless sequences, can improve the diagnostics of patients with human diseases when SRS fails to identify the cause.


  • Open Access

    Comparison of structural variants detected by optical mapping with long-read next-generation sequencing

    by Jakub Savara, Tomáš Novosád, Petr Gajdoš, Eva Kriegová

    Motivation: Recent studies have shown the potential of using long-read whole-genome sequencing (WGS) approaches and optical mapping (OM) for the detection of clinically relevant structural variants (SVs) in cancer research. Three main long-read WGS platforms are currently in use: Pacific Biosciences (PacBio), Oxford Nanopore Technologies (ONT) and 10x Genomics. Recently, whole-genome OM technology (Bionano Genomics) has been introduced into human diagnostics. Questions remain about the accuracy of these long-read sequencing platforms, how comparable/interchangeable they are when searching for SVs and to what extent they can be replaced or supplemented by OM. Moreover, no tool can effectively compare SVs obtained by OM and WGS. Results: This study compared optical maps of the breast cancer cell line SKBR3 with AnnotSV outputs from WGS platforms. For this purpose, a software tool with comparative and filtering features was developed. The majority of SVs up to a 50 kbp distance variance threshold found by OM were confirmed by all WGS platforms, and ∼99% of translocations and ∼80% of deletions found by OM were confirmed by both PacBio and ONT, with ∼70% being confirmed by 10x Genomics in combination with PacBio and/or ONT. Interestingly, long deletions (>100 kbp) were detected only by 10x Genomics. Regarding insertions, ∼74% was confirmed by PacBio and ONT, but none by 10x Genomics. Inversions and duplications detected by OM were not detected by WGS. Moreover, the tool enabled the confirmation of SVs that overlapped in the same gene(s) and was applied to the filtering of disease-associated SVs. Availability and implementation: https://github.com/novosadt/om-annotsv-svc.